Scientists reported: “Our results clearly demonstrate that NIDA cannabis samples are substantially genetically different from most commercially available drug-type strains and share a genetic affinity with hemp samples in several of the analyses.”
The …
Category: University of Mississippi
DEA Announces Intent to License Marijuana Growing Applicants
The DEA’s website did not provide a timeline as to when it anticipates finalizing the applicants’ grow authorizations or when it plans to take actions on the dozens of remaining applications that are still pending before the agency.
The post DEA Announ…
Senate Passes Bill Authorizing Attorney General to Increase Number of Federally Licensed Cannabis Providers
For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.
The post Senate Passes Bill Authorizing Attorney General to Increa…
House Passes Bipartisan Bill Facilitating Clinical Cannabis Research, Allowing Scientists to Access State-Approved Marijuana Products
“These common-sense regulatory changes are necessary and long overdue. The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
The post…
House of Representatives to Vote on Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products
“Legislative action is necessary in this arena because the DEA has proven time and time again that it is not an honest broker in this process.”
The post House of Representatives to Vote on Legislation to Facilitate Clinical Research Studies Using State…
Key Congressional Committee Advances Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products
“The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
The post Key Congressional Committee Advances Legislation to Facilitate Clinic…
NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules
“We believe that the adoption of these rules may further stonewall efforts to advance our scientific understanding of cannabis by unduly expanding the DEA’s authority and control over decisions that ought to be left up to health experts and scientists.”
NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”
“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”
Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis.
Why Dr. Sue Sisley Sued the DEA for Stonewalling Cannabis Research
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses.